These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29981041)

  • 1. Le marché légal du cannabis suite à sa légalisation au Canada : pistes de réflexion pour un encadrement efficace.
    Patenaude C; Brochu S; Fallu JS; Jutras-Aswad D; D'Arcy L
    Can J Public Health; 2018 Apr; 109(2):215-218. PubMed ID: 29981041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation.
    Mahamad S; Wadsworth E; Rynard V; Goodman S; Hammond D
    Drug Alcohol Rev; 2020 May; 39(4):337-346. PubMed ID: 32291811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing New Zealand's Cannabis Legalization and Control Bill: prospects and challenges.
    Wilkins C; Rychert M
    Addiction; 2021 Feb; 116(2):222-230. PubMed ID: 32621400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Zealand's 'Cannabis Legalisation and Regulation Bill': an evidence-based assessment and critique of essential regulatory components towards policy outcomes.
    Fischer B; Daldegan-Bueno D
    N Z Med J; 2020 Jul; 133(1519):103-111. PubMed ID: 32777801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to legal cannabis market in Canada over the four years following non-medical cannabis legalisation.
    Myran DT; Friesen EL; Dickson S; Konikoff L; Arora G; Tanuseputro P
    Drug Alcohol Rev; 2023 Jul; 42(5):1114-1119. PubMed ID: 36933893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critique of cannabis legalization proposals in Canada.
    Kalant H
    Int J Drug Policy; 2016 Aug; 34():5-10. PubMed ID: 27292414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis legalization, regulation, & control: a review of key challenges for local, state, and provincial officials.
    Caulkins JP; Kilborn ML
    Am J Drug Alcohol Abuse; 2019; 45(6):689-697. PubMed ID: 31135218
    [No Abstract]   [Full Text] [Related]  

  • 8. Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: a repeat cross-sectional study.
    Wadsworth E; Rynard V; Driezen P; Freeman TP; Rychert M; Wilkins C; Hall W; Gabrys R; Hammond D
    Harm Reduct J; 2023 Feb; 20(1):19. PubMed ID: 36803833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of select cannabis use and supply indicators pre- and post-legalization in Canada.
    Fischer B; Lee A; Robinson T; Hall W
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):77. PubMed ID: 34620191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in health harms due to cannabis following legalisation of non-medical cannabis in Canada in context of cannabis commercialisation: A scoping review.
    Myran DT; Imtiaz S; Konikoff L; Douglas L; Elton-Marshall T
    Drug Alcohol Rev; 2023 Feb; 42(2):277-298. PubMed ID: 36165188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-Stage Cannabis Regulatory Policy Planning Across Canada's Four Largest Provinces: A Descriptive Overview.
    Watson TM; Hyshka E; Bonato S; Rueda S
    Subst Use Misuse; 2019; 54(10):1691-1704. PubMed ID: 31076006
    [No Abstract]   [Full Text] [Related]  

  • 12. From Toques to Tokes: Two challenges facing nationwide legalization of cannabis in Canada.
    Bear D
    Int J Drug Policy; 2017 Apr; 42():97-101. PubMed ID: 28377052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A missed opportunity? Cannabis legalization and reparations in Canada.
    Valleriani J; Lavalley J; McNeil R
    Can J Public Health; 2018 Dec; 109(5-6):745-747. PubMed ID: 30225575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis.
    Myran DT; Staykov E; Cantor N; Taljaard M; Quach BI; Hawken S; Tanuseputro P
    Drug Alcohol Rev; 2022 Feb; 41(2):377-385. PubMed ID: 34250645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.
    Fischer B; Russell C; Rehm J; Leece P
    J Public Health (Oxf); 2019 Jun; 41(2):412-421. PubMed ID: 29860521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Legalization of cannabis: A Swedish perspective].
    Bejerot S; Glans M
    Lakartidningen; 2021 Jan; 118():. PubMed ID: 33449354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations.
    Fischer B; Daldegan-Bueno D; Boden JM
    Drug Alcohol Rev; 2020 Jul; 39(5):555-567. PubMed ID: 32436274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triangulating web & general population surveys: Do results match legal cannabis market sales?
    Caulkins JP; Davenport S; Doanvo A; Furlong K; Siddique A; Turner M; Kilmer B
    Int J Drug Policy; 2019 Nov; 73():293-300. PubMed ID: 31272752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of marijuana purchase task based demand functions for optimal legal pricing of cannabis.
    Childs J; Poirier A
    Int J Drug Policy; 2021 Sep; 95():103271. PubMed ID: 34049233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-medical cannabis in North America: an overview of regulatory approaches.
    Lancione S; Wade K; Windle SB; Filion KB; Thombs BD; Eisenberg MJ
    Public Health; 2020 Jan; 178():7-14. PubMed ID: 31600630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.